Treatment Imperial patients among first in world to receive pioneering gene-editing treatment for high cholesterol

Single Infusion of Gene-Editing Therapy VERVE-102 Shows Promise for Inherited High Cholesterol

Learn how gene editing may help people born with dangerously high cholesterol lower their levels with just one infusion.

Eli Lilly's experimental gene-editing therapy VERVE-102 shows promise as one-time treatment for high cholesterol

Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer for treating high cholesterol.

Gene Editing May Help Treat Dangerously High Cholesterol with Just One Infusion

Single treatment for familial hypercholesterolemia looks promising in this small, initial clinical trial.

Rewriting genetic medicine

Scribe Therapeutics will soon begin clinical trials for its epigenetic treatment to tackle ‘bad’ cholesterol

FDA approves first-of-its-kind pill to cut cholesterol in high-risk patients

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients